HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹367 Cr | ₹423 Cr | ₹490 Cr | ₹287 Cr | ₹263 Cr |
What is the latest Secured Loans ratio of HIKAL ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹423 Cr |
| Mar2023 | ₹490 Cr |
| Mar2022 | ₹287 Cr |
| Mar2021 | ₹263 Cr |
How is Secured Loans of HIKAL Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | -13.17 | |
| Mar2024 | ₹423 Cr | -13.67 | |
| Mar2023 | ₹490 Cr | 70.88 | |
| Mar2022 | ₹287 Cr | 9.05 | |
| Mar2021 | ₹263 Cr | - | |
Compare Secured Loans of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,491.3 Cr | -0% | 5.6% | -43.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0% |
5.6% |
-43.4% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses